Covid-19 roundup: After batting back at vaccine supplier, Inovio lines up a giant in its corner; Oxford spinout SpyBiotech begins PhI/II dosing for VLP-based vaccine
Inovio announced Tuesday morning that manufacturing giant Thermo Fisher has signed on to make their Covid-19 vaccine INO-4800 in 2021. The biotech — which has yet to get an OK on a vaccine after more than 40 years of operations — expects to be able to distribute 100 million doses to help end the Covid-19 pandemic, but first it has to get around a recalcitrant manufacturer that controls much of the IP used to make the biotech’s vaccines.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
